Nelmastobart
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nelmastobart, covering 2025-07-11 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer [Phase 2]